Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC. Jung HA, Lim J, Choi YL, Lee SH, et al. Clin Cancer Res 2022;28:4312-4321.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jung HA, Lim J, Choi YL, Lee SH, et al. Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC. Clin Cancer Res 2022;28:4312-4321.
PMID: 35838647